BioCentury
ARTICLE | Regulation

Coalition of regulators call coordinated trials key to fighting COVID-19

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 10, 2020 12:25 AM UTC

EMA and other international regulators are emphasizing the need for robust clinical trials to rapidly determine the most promising COVID-19 candidates.

On Thursday, EMA set objectives for its COVID-19 task force, and the International Coalition of Medicines Regulatory Authorities (ICMRA) released a report from a workshop that recommended more controlled trials over compassionate use programs. ...